ArticleJCI insight2024
Polyclonal antibodies selectively inhibit tumor growth and invasion and synergize with immune checkpoint inhibitors.
Carine Ciron et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it